{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/incyte-corporation/","json":"https://alysly.com/json/markets/stocks/incyte-corporation/index.json","lang":"en-US","title":"Incyte Corporation (INCY) Stock Price Today | US45337C1027","description":"Incyte Corporation (INCY). Revenue $5.1bn, net margin 25.0% (FY ended Dec 2025). ISIN US45337C1027 · WKN 896133.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/incyte-corporation/","json":"https://alysly.com/json/de/maerkte/aktien/incyte-corporation/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Incyte Corporation","url":"https://alysly.com/markets/stocks/incyte-corporation/"}],"content":[{"type":"heading","level":1,"text":"Incyte Corporation (INCY)"},{"type":"paragraph","text":"INCY · Health Care · United States","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"United States","href":"https://alysly.com/markets/stocks/browse/?country=United%20States"}]},{"type":"paragraph","text":"Incyte Corporation (INCY) is a US company in the Health Care sector. The stock has its largest weight in XDEB (MSCI World Minimum Volatility), at 0.43%. Anyone who holds an ETF containing Incyte Corporation also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Incyte Corporation"},{"type":"heading","level":3,"text":"Key Data for Incyte Corporation"},{"type":"facts","items":[{"label":"Held in","value":"23 ETFs"},{"label":"Highest weight","value":"0.43%"},{"label":"Indices","value":"12"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"United States"},{"label":"ISIN","value":"US45337C1027"},{"label":"WKN","value":"896133"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"Incyte Corporation Stock Price Chart"},{"type":"paragraph","text":"The Incyte Corporation chart shows daily closing prices and is set to the current year by default. The stock is up 21.9% year to date and up 30.0% over twelve months. The last recorded close on October 30, 2026, was $120.39, at 76% of the 52-week range."},{"type":"paragraph","text":"Price series from our database since Aug 12, 2024, 558 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Incyte Corporation Stock Performance"},{"type":"table","caption":"Incyte Corporation stock performance","rows":[["Year to date","+21.9%","1 year","+30.0%"],["1 month","-0.8%","3 months","+0.7%"],["Calendar year 2025","+43.0%","",""]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, Incyte Corporation is up 28.2% year to date and up 34.4% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Incyte Corporation"},{"type":"heading","level":3,"text":"What ETF Is Incyte Corporation In?"},{"type":"paragraph","text":"Incyte Corporation has above-average ETF coverage and is held by 23 of the 104 ETFs we track, which together follow 12 indices. That puts the stock in more ETFs than 87.8% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is Incyte Corporation in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"XDEB","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-minimum-volatility-ucits-etf-1c/"},{"text":"MSCI World Minimum Volatility","href":"https://alysly.com/markets/indices/msci-world-minimum-volatility/"},"0.43%","€4.25"],[{"text":"XUHL / XUHC","links":[{"text":"XUHL","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-health-care-ucits-etf-1c/"}]},{"text":"MSCI USA Health Care","href":"https://alysly.com/markets/indices/msci-usa-health-care/"},"0.30%","€2.95"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.22%","€2.19"],[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.22%","€2.17"],[{"text":"XDEW","href":"https://alysly.com/markets/etfs/xtrackers-sp-500-equal-weight-ucits-etf-1c/"},{"text":"S&P 500 Equal Weight","href":"https://alysly.com/markets/indices/sp500-equal-weight/"},"0.18%","€1.81"],[{"text":"2B7K","href":"https://alysly.com/markets/etfs/ishares-msci-world-sri-ucits-etf-eur-acc/"},{"text":"MSCI World SRI","href":"https://alysly.com/markets/indices/msci-world-sri/"},"0.09%","€0.90"],[{"text":"XDEV","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-value-ucits-etf-1c/"},{"text":"MSCI World Value","href":"https://alysly.com/markets/indices/msci-world-value/"},"0.08%","€0.76"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.06%","€0.57"],[{"text":"SXR8","href":"https://alysly.com/markets/etfs/ishares-core-sp-500-ucits-etf-acc/"},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.03%","€0.30"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.03%","€0.30"],[{"text":"XD9U / XD9D","links":[{"text":"XD9U","href":"https://alysly.com/markets/etfs/xtrackers-msci-usa-ucits-etf-1c/"}]},{"text":"MSCI USA","href":"https://alysly.com/markets/indices/msci-usa/"},"0.03%","€0.30"],[{"text":"SPYL / SPY5","links":[{"text":"SPYL","href":"https://alysly.com/markets/etfs/state-street-spdr-sp-500-ucits-etf-acc/"}]},{"text":"S&P 500","href":"https://alysly.com/markets/indices/sp500/"},"0.03%","€0.28"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.22"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.22"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.22"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.02%","€0.20"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.02%","€0.20"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.02%","€0.19"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Incyte Corporation, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Incyte Corporation (weight per latest SEC filing): ONEQ 0.05%, IVV 0.03%, SPY 0.03%, VOO 0.03%, VTI 0.03%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"ONEQ","href":"https://alysly.com/markets/etfs/us/oneq/"},{"text":"IVV","href":"https://alysly.com/markets/etfs/us/ivv/"},{"text":"SPY","href":"https://alysly.com/markets/etfs/us/spy/"},{"text":"VOO","href":"https://alysly.com/markets/etfs/us/voo/"},{"text":"VTI","href":"https://alysly.com/markets/etfs/us/vti/"}]},{"type":"list","ordered":false,"items":[{"text":"Incyte Corporation among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 23 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Incyte Corporation Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"Incyte Corporation: weight in EUNL 0.03% → 0.02%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 30, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), Incyte Corporation had a weight of 0.03% on Sep 30, 2019 and 0.02% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.04% on Jun 30, 2020. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Incyte Corporation overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Which Tracked Investors Hold Incyte Corporation?"},{"type":"paragraph","text":"Incyte Corporation is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds Incyte Corporation increased its position.","links":[{"text":"GOOGL","href":"https://alysly.com/markets/stocks/alphabet-inc-class-a/"}]},{"type":"table","caption":"Tracked investors holding this stock","columns":["Investor","Shares","Value","Quarter"],"rows":[["Bridgewater Associates","168,253","$19M","increased by 37,957"]]},{"type":"paragraph","text":"As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"What Incyte Corporation Executives and Directors Traded Recently"},{"type":"table","caption":"Trades by executives and directors","columns":["Date","Person","Type","Shares","Price"],"rows":[["Oct 15, 2026","CAGNONI PABLO J Officer, President, Global Head of R&D","Sell","2,642","$112.71"]]},{"type":"paragraph","text":"The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded."},{"type":"paragraph","text":"“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Incyte Corporation"},{"type":"table","caption":"Stocks with ETF exposure similar to Incyte Corporation","columns":["Stock","Shared ETFs","r","1 year","Annualized volatility","Net margin","Revenue growth"],"rows":[["Incyte Corporation","–","–","+30.0%","34.0%","25.0%","+21.2%"],[{"text":"Cigna Group","href":"https://alysly.com/markets/stocks/the-cigna-group/"},"23","–","+20.7%","30.5%","2.2%","+11.2%"],[{"text":"Elevance Health","href":"https://alysly.com/markets/stocks/elevance-health-inc/"},"23","–","+30.5%","34.7%","2.8%","+12.5%"],[{"text":"Edwards Lifesciences Corporation","href":"https://alysly.com/markets/stocks/edwards-lifesciences-corporation/"},"22","–","+10.2%","25.0%","17.7%","+11.5%"],[{"text":"HCA Healthcare Inc","href":"https://alysly.com/markets/stocks/hca-healthcare-inc/"},"22","–","+1.4%","29.0%","9.0%","+7.1%"],[{"text":"Labcorp Holdings","href":"https://alysly.com/markets/stocks/labcorp-holdings-inc/"},"22","–","+43.2%","23.7%","6.3%","+7.2%"],[{"text":"Centene Corporation","href":"https://alysly.com/markets/stocks/centene-corporation/"},"23","–","+95.5%","50.4%","-3.4%","+19.4%"],[{"text":"Quest Diagnostics Incorporated","href":"https://alysly.com/markets/stocks/quest-diagnostics-incorporated/"},"22","–","+43.3%","22.9%","9.0%","+11.8%"],[{"text":"Cooper Companies","href":"https://alysly.com/markets/stocks/cooper/"},"22","–","-15.1%","33.3%","9.2%","+5.1%"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Incyte Corporation. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical."},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Incyte Corporation"},{"type":"heading","level":3,"text":"Incyte Corporation Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$5.1B"},{"label":"Net income","value":"$1.3B"},{"label":"Diluted EPS","value":"$6.41"},{"label":"Net margin","value":"25.0%"},{"label":"Return on equity","value":"24.9%"},{"label":"Equity ratio","value":"74.3%"},{"label":"Revenue growth","value":"+21.2%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","3.7","0.6","16.2%"],["FY ended Dec 2024","4.2","0.0","0.8%"],["FY ended Dec 2025","5.1","1.3","25.0%"]]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Incyte Corporation"},{"type":"heading","level":3,"text":"Incyte Corporation Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-33.8%"},{"label":"Annualized volatility","value":"34.0%"}]},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"facts","items":[{"label":"Below peak","value":"-7.3%"},{"label":"Beta to S&P 500","value":"0.33"},{"label":"Correlation to S&P 500","value":"0.13"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was 7.3% below the highest close since Aug 12, 2024. That high was reached on Jul 28, 2026. When the S&P 500 rose or fell 1%, Incyte Corporation moved 0.33% on average in the same direction (past 252 trading days). The correlation of 0.13, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Incyte Corporation."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":3,"text":"What Incyte Corporation Correlates With"},{"type":"table","caption":"What Incyte Corporation Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Royalty Pharma Plc Class A","href":"https://alysly.com/markets/stocks/royalty-pharma-plc-class-a/"},"+0.61",""],[{"text":"Vertex Pharmaceuticals Incorporated","href":"https://alysly.com/markets/stocks/vertex-pharmaceuticals-incorporated/"},"+0.60",""],[{"text":"Gilead Sciences Inc.","href":"https://alysly.com/markets/stocks/gilead-sciences-inc/"},"+0.59",""],[{"text":"Pfizer Inc.","href":"https://alysly.com/markets/stocks/pfizer-inc/"},"+0.58",""],[{"text":"Amgen Inc.","href":"https://alysly.com/markets/stocks/amgen-inc/"},"+0.56",""],[{"text":"Eli Lilly and Company","href":"https://alysly.com/markets/stocks/eli-lilly-and-company/"},"+0.55",""],[{"text":"SAPIEN","href":"https://alysly.com/markets/crypto/sapien/"},"-0.56",""],[{"text":"Nikkei 225","href":"https://alysly.com/markets/indices/nikkei-225/"},"-0.44",""],[{"text":"nVent Electric plc","href":"https://alysly.com/markets/stocks/nvent-electric-plc/"},"-0.43",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 14","href":"#dn-14"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Incyte Corporation"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-8","text":"Holdings as of quarter end from the mandatory filings (Form 13F) with the US securities regulator; the deadline runs up to 45 days."},{"id":"dn-9","text":"Purchases and sales by directors, officers and ten-percent owners from Form 4 filings with the US securities regulator, reported two trading days after the transaction."},{"id":"dn-10","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-11","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-12","text":"Computed from the full available price history."},{"id":"dn-13","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-14","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/incyte-corporation/#webpage","url":"https://alysly.com/markets/stocks/incyte-corporation/","name":"Incyte Corporation – Alysly","description":"Incyte Corporation (INCY). Revenue $5.1bn, net margin 25.0% (FY ended Dec 2025). ISIN US45337C1027 · WKN 896133.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/incyte-corporation/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Incyte Corporation"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/incyte-corporation/#entity","name":"Incyte Corporation","tickerSymbol":"INCY","url":"https://alysly.com/markets/stocks/incyte-corporation/","mainEntityOfPage":"https://alysly.com/markets/stocks/incyte-corporation/","description":"Incyte Corporation (INCY). Revenue $5.1bn, net margin 25.0% (FY ended Dec 2025). ISIN US45337C1027 · WKN 896133.","logo":"https://alysly.com/stock-logos/incyte-corporation-logo.webp","image":"https://alysly.com/stock-logos/incyte-corporation-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"INCY"},{"@type":"PropertyValue","propertyID":"ISIN","value":"US45337C1027"},{"@type":"PropertyValue","propertyID":"WKN","value":"896133"}],"address":{"@type":"PostalAddress","addressCountry":"US"},"subjectOf":{"@type":"Dataset","name":"Incyte Corporation — key figures","url":"https://alysly.com/markets/stocks/incyte-corporation/","description":"Incyte Corporation (INCY). Revenue $5.1bn, net margin 25.0% (FY ended Dec 2025). ISIN US45337C1027 · WKN 896133.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":23},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.4251},{"@type":"PropertyValue","name":"YTD return (%)","value":21.9},{"@type":"PropertyValue","name":"1-year return (%)","value":30},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":5141242000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":1286650000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":6957973000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":5167478000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":6.41},{"@type":"PropertyValue","name":"Net margin (%)","value":25},{"@type":"PropertyValue","name":"Return on equity (%)","value":24.9},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2024-08-12/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}